Merck & Co. Inc. buy BMO Capital Markets
Start price
27.10.23
/
50%
€101.00
Target price
27.10.24
€125.02
Performance (%)
20.80%
Price
08:00
€120.60
Summary
This prediction is currently active. The prediction currently has a performance of 20.80%. A total of €1.41 was paid as dividends for this prediction. This prediction currently runs until 27.10.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 1.000% | 1.000% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $132.00 price target on the stock.
Ratings data for MRK provided by MarketBeat